Objective There are few data regarding the effect of the Stenting and Aggressive Medical
Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial …

Medicine. 1 The trial was a randomized controlled trial which was sponsored by the National
Institutes of Health (clinicaltrials. gov number, NCT0057693). Entrance into the trial required …

The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and
Intracranial Stenosis (SAMMPRIS) trial, a randomized clinical trial comparing aggressive …

The recently published Stenting versus Aggressive Medical Management for Preventing
Recurrent stroke in Intracranial Stenosis (SAMMPRIS) study1 has provided seminal …

Importance The Stenting and Aggressive Medical Management for Preventing Recurrent
Stroke in Intracranial Stenosis (SAMMPRIS) Trial showed that aggressive medical therapy …

Intracranial atherosclerotic disease (ICAD) accounts for 33–50% of all ischemic strokes in
the Asian population and represents an important public health issue in China. The results …

ABSTRACT OBJECTIVE The results of prematurely terminated stenting and aggressive
medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) …

Background and purpose High periprocedural complication rate is a key limitation of
endovascular treatment of intracranial atherosclerotic disease (ICAD), despite potential risk …

The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in
Intracranial Stenosis trial1 (SAMMPRIS, ClinicalTrials. gov number, NCT00576693), as …

The management of intracranial atherosclerotic disease (ICAD) has been evolving with
advanced imaging, refinements of best medical treatment, and the development of …